国际妇产科学杂志 ›› 2026, Vol. 53 ›› Issue (2): 237-240.doi: 10.12280/gjfckx.20251344

• 妇科肿瘤研究: 病例报告 • 上一篇    

晚期卵巢癌腹腔穿刺引流术后继发腹壁穿刺孔转移一例

张梦杰, 焦今文, 王黎明()   

  1. 266000 青岛大学附属医院妇科
  • 收稿日期:2025-12-01 出版日期:2026-04-15 发布日期:2026-05-08
  • 通讯作者: 王黎明 E-mail:wlmqingyi@163.com

A Case of Port Site Metastasis Secondary to Abdominal Paracentesis Drainage in Advanced Ovarian Cancer

ZHANG Meng-jie, JIAO Jin-wen, WANG Li-ming()   

  1. Department of Gynecology, The Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China
  • Received:2025-12-01 Published:2026-04-15 Online:2026-05-08
  • Contact: WANG Li-ming E-mail:wlmqingyi@163.com

摘要:

作为卵巢癌腹腔穿刺引流术罕见的并发症,腹壁穿刺孔转移(port site metastasis,PSM)是指肿瘤组织出现在穿刺孔或其附近的皮下组织内。报告1例晚期卵巢癌腹腔穿刺引流术后继发PSM的病例。患者因腹胀就诊,超声及增强CT显示大量腹腔积液,行腹腔穿刺引流术,腹水细胞学病理检查确诊女性生殖系统来源的浆液性癌,予以铂类为基础的新辅助化疗,第1个周期加用贝伐珠单抗。腹腔穿刺引流术后1个月余患者自行扪及左下腹有一肿物,超声显示左侧腹壁浅筋膜层见低回声结节。3个周期新辅助化疗结束后行间歇性肿瘤细胞减灭术及腹壁病灶切除术,术后病理证实腹壁肿物系卵巢癌转移。患者术后定期复查,腹壁暂未见复发。同时结合相关文献,进一步探讨晚期卵巢癌腹腔穿刺引流术后发生PSM的危险因素、发病机制及防治策略。

关键词: 穿刺抽液术, 卵巢肿瘤, 癌, 肿瘤转移, 基因,BRCA1, 腹腔穿刺引流, 腹壁穿刺孔转移

Abstract:

Port site metastasis (PSM) is a rare complication of abdominal paracentesis drainage in ovarian cancer, referring to the occurrence of tumor tissue within the subcutaneous tissue at or adjacent to the puncture site. This report presents a case of PSM secondary to abdominal paracentesis drainage in a patient with advanced ovarian cancer. The patient presented with abdominal distension. Ultrasonography and contrast-enhanced CT revealed massive ascites. Abdominal paracentesis drainage was performed, and cytopathological examination of the ascitic fluid confirmed serous carcinoma of gynecological origin. Platinum-based neoadjuvant chemotherapy was initiated, with bevacizumab added during the first cycle. Approximately one month after the paracentesis, the patient self-palpated a mass in the left lower abdomen. Ultrasonography revealed a hypoechoic nodule within the superficial fascia layer of the left abdominal wall. After three cycles of neoadjuvant chemotherapy, interval tumor cytoreductive surgery and resection of the abdominal wall lesion were performed. Postoperative pathology confirmed that the abdominal wall mass represented a metastasis from ovarian cancer. The patient has been followed up regularly, and no recurrence has been observed at the abdominal wall site. Combined with a review of relevant literature, this report further discusses the risk factors, pathogenesis, and prevention strategies for PSM following abdominal paracentesis drainage in advanced ovarian cancer.

Key words: Paracentesis, Ovarian neoplasms, Carcinoma, Neoplasm metastasis, Genes, BRCA1, Abdominal paracentesis drainage, Port site metastasis